Literature DB >> 23734574

Trends in resource utilization associated with the inpatient treatment of neonatal congenital heart disease.

Andrew H Smith1, James C Gay, Neal R Patel.   

Abstract

INTRODUCTION: While neonates account for a significant proportion of health care expenditures related to inpatient care for congenital heart disease, key drivers of resource utilization among this population are poorly defined.
METHODS: Data from 2005 through 2011 were extracted from the Pediatric Health Information System for patients assigned a discharge All Patient Refined Diagnosis Related Group of 630 (neonates with birthweight >2499 g undergoing a major cardiovascular procedure). Mortality risk adjustment for patients undergoing operative interventions was performed with the Risk Adjusment in Congenital Heart Surgery (RACHS-1) score.
RESULTS: A total of 13 156 cases were included in the analysis. Despite only a 3% increase in case mix index and no significant change in operative acuity over the study period (RACHS classifications of 3 or greater 67% in 2005 vs. 66% in 2011, P = .64), there were inflation-adjusted increases in both total estimated cost per case of (50% to $151 760 in 2011, P < .001), and mean charge per case (33% to $433 875 in 2011, P < .001). Pharmacy charges increased by 16% (P < .001), with agents including chlorothiazide and albumin accounting for the highest patient charges over the study period. Imaging charges increased by 42% (P < .001), with an average of 5.7 echocardiograms and $6517 in associated charges per case by 2011. While the proportion of patients receiving nitric oxide remained consistent, mean duration of administration increased by 25% to 6.6 days by 2011, accounting for average charges of $52 141 per patient exposed.
CONCLUSIONS: Among neonates with serious congenital heart disease, increases in both institutional costs and charges to the patient are associated with relatively consistent utilization practices in recent years. Multiinstitutional collaboration may prove useful in aligning evidence-based reductions in practice variation with limitations in resource utilization without compromising the quality of care.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Congenital; Cost and Cost Analysis; Health Resources; Heart Defects; Pediatrics

Mesh:

Year:  2013        PMID: 23734574     DOI: 10.1111/chd.12103

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  12 in total

1.  The Impact of Differential Case Ascertainment in Clinical Registry Versus Administrative Data on Assessment of Resource Utilization in Pediatric Heart Surgery.

Authors:  David W Jantzen; Xia He; Jeffrey P Jacobs; Marshall L Jacobs; Michael G Gaies; Matt Hall; John E Mayer; Samir S Shah; Jennifer Hirsch-Romano; J William Gaynor; Eric D Peterson; Sara K Pasquali
Journal:  World J Pediatr Congenit Heart Surg       Date:  2014-07

2.  Variation in congenital heart surgery costs across hospitals.

Authors:  Sara K Pasquali; Marshall L Jacobs; Xia He; Samir S Shah; Eric D Peterson; Matthew Hall; J William Gaynor; Kevin D Hill; John E Mayer; Jeffrey P Jacobs; Jennifer S Li
Journal:  Pediatrics       Date:  2014-02-24       Impact factor: 7.124

3.  Gestational age at birth and outcomes after neonatal cardiac surgery: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database.

Authors:  John M Costello; Sara K Pasquali; Jeffrey P Jacobs; Xia He; Kevin D Hill; David S Cooper; Carl L Backer; Marshall L Jacobs
Journal:  Circulation       Date:  2014-05-02       Impact factor: 29.690

4.  Variability in noncardiac surgical procedures in children with congenital heart disease.

Authors:  Jason P Sulkowski; Jennifer N Cooper; Patrick I McConnell; Sara K Pasquali; Samir S Shah; Peter C Minneci; Katherine J Deans
Journal:  J Pediatr Surg       Date:  2014-07-11       Impact factor: 2.545

5.  Characterization of Inhaled Nitric Oxide Use for Cardiac Indications in Pediatric Patients.

Authors:  Andrew R Yates; John T Berger; Ron W Reeder; Russell Banks; Peter M Mourani; Robert A Berg; Joseph A Carcillo; Todd Carpenter; Mark W Hall; Kathleen L Meert; Patrick S McQuillen; Murray M Pollack; Anil Sapru; Daniel A Notterman; Richard Holubkov; J Michael Dean; David L Wessel
Journal:  Pediatr Crit Care Med       Date:  2022-02-23       Impact factor: 3.971

6.  Admission to dedicated pediatric cardiac intensive care units is associated with decreased resource use in neonatal cardiac surgery.

Authors:  Joyce T Johnson; Jacob F Wilkes; Shaji C Menon; Lloyd Y Tani; Hsin-Yi Weng; Bradley S Marino; Nelangi M Pinto
Journal:  J Thorac Cardiovasc Surg       Date:  2018-02-21       Impact factor: 5.209

7.  Longitudinal Health Care Cost in Hypoplastic Left Heart Syndrome Palliation.

Authors:  Jesse E Hansen; Nicolas L Madsen; Laurie Bishop; David L S Morales; Jeffrey B Anderson
Journal:  Pediatr Cardiol       Date:  2018-05-17       Impact factor: 1.655

8.  Right Ventricular Outflow Tract Reintervention in the Transcatheter Era: Outcomes and Cost Analysis.

Authors:  Danielle Crethers; Joshua Kalish; Brendan Shafer; Lauren Mathis; Anastasios C Polimenakos
Journal:  Pediatr Cardiol       Date:  2020-01-02       Impact factor: 1.655

9.  Development of a charge adjustment model for cardiac catheterization.

Authors:  Andrew Brennan; Kimberlee Gauvreau; Jean Connor; Cheryl O'Connell; Sthuthi David; Melvin Almodovar; James DiNardo; Puja Banka; John E Mayer; Audrey C Marshall; Lisa Bergersen
Journal:  Pediatr Cardiol       Date:  2014-08-12       Impact factor: 1.655

10.  Factors That Contribute to Cost Differences Based on ICU of Admission in Neonates Undergoing Congenital Heart Surgery: A Novel Decomposition Analysis.

Authors:  Joyce T Johnson; Kirsen L Sullivan; Richard E Nelson; Xiaoming Sheng; Tom H Greene; David K Bailly; Aaron W Eckhauser; Bradley S Marino; L LuAnn Minich; Nelangi M Pinto
Journal:  Pediatr Crit Care Med       Date:  2020-09       Impact factor: 3.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.